113 related articles for article (PubMed ID: 24600036)
1. PIKfyve, a class III lipid kinase, is required for TLR-induced type I IFN production via modulation of ATF3.
Cai X; Xu Y; Kim YM; Loureiro J; Huang Q
J Immunol; 2014 Apr; 192(7):3383-9. PubMed ID: 24600036
[TBL] [Abstract][Full Text] [Related]
2. PIKfyve, a class III PI kinase, is the target of the small molecular IL-12/IL-23 inhibitor apilimod and a player in Toll-like receptor signaling.
Cai X; Xu Y; Cheung AK; Tomlinson RC; Alcázar-Román A; Murphy L; Billich A; Zhang B; Feng Y; Klumpp M; Rondeau JM; Fazal AN; Wilson CJ; Myer V; Joberty G; Bouwmeester T; Labow MA; Finan PM; Porter JA; Ploegh HL; Baird D; De Camilli P; Tallarico JA; Huang Q
Chem Biol; 2013 Jul; 20(7):912-21. PubMed ID: 23890009
[TBL] [Abstract][Full Text] [Related]
3. ATF3 Is a Key Regulator of Macrophage IFN Responses.
Labzin LI; Schmidt SV; Masters SL; Beyer M; Krebs W; Klee K; Stahl R; Lütjohann D; Schultze JL; Latz E; De Nardo D
J Immunol; 2015 Nov; 195(9):4446-55. PubMed ID: 26416280
[TBL] [Abstract][Full Text] [Related]
4. The Lipid Kinase PIKfyve Coordinates the Neutrophil Immune Response through the Activation of the Rac GTPase.
Dayam RM; Sun CX; Choy CH; Mancuso G; Glogauer M; Botelho RJ
J Immunol; 2017 Sep; 199(6):2096-2105. PubMed ID: 28779020
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 9 trafficking and signaling for type I interferons requires PIKfyve activity.
Hayashi K; Sasai M; Iwasaki A
Int Immunol; 2015 Sep; 27(9):435-45. PubMed ID: 25925170
[TBL] [Abstract][Full Text] [Related]
6. Scaffolding adaptor protein Gab1 is required for TLR3/4- and RIG-I-mediated production of proinflammatory cytokines and type I IFN in macrophages.
Zheng Y; An H; Yao M; Hou J; Yu Y; Feng G; Cao X
J Immunol; 2010 Jun; 184(11):6447-56. PubMed ID: 20435932
[TBL] [Abstract][Full Text] [Related]
7. The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity.
Wang Y; Shaked I; Stanford SM; Zhou W; Curtsinger JM; Mikulski Z; Shaheen ZR; Cheng G; Sawatzke K; Campbell AM; Auger JL; Bilgic H; Shoyama FM; Schmeling DO; Balfour HH; Hasegawa K; Chan AC; Corbett JA; Binstadt BA; Mescher MF; Ley K; Bottini N; Peterson EJ
Immunity; 2013 Jul; 39(1):111-22. PubMed ID: 23871208
[TBL] [Abstract][Full Text] [Related]
8. Histone lysine methyltransferase Ezh1 promotes TLR-triggered inflammatory cytokine production by suppressing Tollip.
Liu Y; Zhang Q; Ding Y; Li X; Zhao D; Zhao K; Guo Z; Cao X
J Immunol; 2015 Mar; 194(6):2838-46. PubMed ID: 25687760
[TBL] [Abstract][Full Text] [Related]
9. Induction of Systemic Autoimmunity by a Xenobiotic Requires Endosomal TLR Trafficking and Signaling from the Late Endosome and Endolysosome but Not Type I IFN.
Pollard KM; Escalante GM; Huang H; Haraldsson KM; Hultman P; Christy JM; Pawar RD; Mayeux JM; Gonzalez-Quintial R; Baccala R; Beutler B; Theofilopoulos AN; Kono DH
J Immunol; 2017 Dec; 199(11):3739-3747. PubMed ID: 29055005
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional Regulation of PIK3CD and PIKFYVE in T-Cell Acute Lymphoblastic Leukemia by IKAROS and Protein Kinase CK2.
Dovat E; Song C; Hu T; Rahman MA; Dhanyamraju PK; Klink M; Bogush D; Soliman M; Kane S; McGrath M; Ding Y; Desai D; Sharma A; Gowda C
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467550
[TBL] [Abstract][Full Text] [Related]
11. Negative regulation of TLR-signaling pathways by activating transcription factor-3.
Whitmore MM; Iparraguirre A; Kubelka L; Weninger W; Hai T; Williams BR
J Immunol; 2007 Sep; 179(6):3622-30. PubMed ID: 17785797
[TBL] [Abstract][Full Text] [Related]
12. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.
Gotoh K; Tanaka Y; Nishikimi A; Nakamura R; Yamada H; Maeda N; Ishikawa T; Hoshino K; Uruno T; Cao Q; Higashi S; Kawaguchi Y; Enjoji M; Takayanagi R; Kaisho T; Yoshikai Y; Fukui Y
J Exp Med; 2010 Apr; 207(4):721-30. PubMed ID: 20231379
[TBL] [Abstract][Full Text] [Related]
13. The second messenger phosphatidylinositol-5-phosphate facilitates antiviral innate immune signaling.
Kawasaki T; Takemura N; Standley DM; Akira S; Kawai T
Cell Host Microbe; 2013 Aug; 14(2):148-58. PubMed ID: 23954154
[TBL] [Abstract][Full Text] [Related]
14. TLR ligands induce synergistic interferon-β and interferon-λ1 gene expression in human monocyte-derived dendritic cells.
Mäkelä SM; Osterlund P; Julkunen I
Mol Immunol; 2011 Jan; 48(4):505-15. PubMed ID: 21040977
[TBL] [Abstract][Full Text] [Related]
15. Unexpected inhibition of the lipid kinase PIKfyve reveals an epistatic role for p38 MAPKs in endolysosomal fission and volume control.
Wible DJ; Parikh Z; Cho EJ; Chen MD; Jeter CR; Mukhopadhyay S; Dalby KN; Varadarajan S; Bratton SB
Cell Death Dis; 2024 Jan; 15(1):80. PubMed ID: 38253602
[TBL] [Abstract][Full Text] [Related]
16. Apilimod, a candidate anticancer therapeutic, arrests not only PtdIns(3,5)P2 but also PtdIns5P synthesis by PIKfyve and induces bafilomycin A1-reversible aberrant endomembrane dilation.
Sbrissa D; Naisan G; Ikonomov OC; Shisheva A
PLoS One; 2018; 13(9):e0204532. PubMed ID: 30240452
[TBL] [Abstract][Full Text] [Related]
17. Snx10 and PIKfyve are required for lysosome formation in osteoclasts.
Sultana F; Morse LR; Picotto G; Liu W; Jha PK; Odgren PR; Battaglino RA
J Cell Biochem; 2020 Apr; 121(4):2927-2937. PubMed ID: 31692073
[TBL] [Abstract][Full Text] [Related]
18. Absence of SHIP-1 results in constitutive phosphorylation of tank-binding kinase 1 and enhanced TLR3-dependent IFN-beta production.
Gabhann JN; Higgs R; Brennan K; Thomas W; Damen JE; Ben Larbi N; Krystal G; Jefferies CA
J Immunol; 2010 Mar; 184(5):2314-20. PubMed ID: 20100929
[TBL] [Abstract][Full Text] [Related]
19. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4.
Gilchrist M; Thorsson V; Li B; Rust AG; Korb M; Roach JC; Kennedy K; Hai T; Bolouri H; Aderem A
Nature; 2006 May; 441(7090):173-8. PubMed ID: 16688168
[TBL] [Abstract][Full Text] [Related]
20. The induction of STAT1 gene by activating transcription factor 3 contributes to pancreatic beta-cell apoptosis and its dysfunction in streptozotocin-treated mice.
Kim JY; Song EH; Lee S; Lim JH; Choi JS; Koh IU; Song J; Kim WH
Cell Signal; 2010 Nov; 22(11):1669-80. PubMed ID: 20600850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
